SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Kidney Disease Sweat sensor patch for Early diagnosis and Remote MonIToring

The KERMIT project aims to develop a cost-effective, disposable sweat patch for non-invasive early detection and remote monitoring of chronic kidney disease biomarkers.

Subsidie
€ 3.080.623
2023

Projectdetails

Introduction

Human sweat is abundant with biomarkers that provide information about underlying health conditions. In combination with the capabilities of wearable devices, sweat monitoring offers a promising pathway to continuous healthcare.

Chronic Kidney Disease (CKD)

Chronic kidney disease (CKD) is a long-term condition in which waste cannot be removed from the bloodstream, potentially leading to recurring infections and early cardiovascular disease. It affects over 100 million people in Europe alone and can go unnoticed until severe symptoms appear.

Potential for Non-Invasive Screening

There is enormous potential to develop non-invasive mass screening technologies for early diagnosis and monitoring, which can lead to preventive treatment.

Project Proposal: KERMIT

Here, we propose a kidney disease sweat patch for early detection and remote monitoring (KERMIT). This project merges three main concepts:

  1. Development of a cost-effective and disposable sensing platform with minimal environmental impact.
  2. Unobtrusive detection of three CKD biomarkers (cystatin-c, creatinine, and urea) from sweat.
  3. Association of sweat-based concentration with blood levels, symptoms, and overall disease progress.

Platform Design

The simplified disposable platform includes:

  • An iontophoresis device to produce sweat.
  • A microfluidics collection system.
  • A single chip to power, read, analyze, and wirelessly transmit data from various electrochemical sensors through smartphone RF/NFC protocols.

Manufacturing and Sustainability

The manufacturing process utilizes scalable printing techniques with sustainable materials, ensuring cost-effectiveness while minimizing environmental impact after disposal.

Validation and Impact

Through quantitative comparison with standard testing methodologies, the proposed system is envisioned to increase knowledge and validate sweat-based non-invasive diagnostics for CKD and a variety of diseases. This will allow for non-invasive routine screening of populations at risk and remote health monitoring, opening opportunities for targeted hospital and government health programs.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 3.080.623
Totale projectbegroting€ 3.080.623

Tijdlijn

Startdatum1-7-2023
Einddatum30-6-2026
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • SILICON AUSTRIA LABS GMBHpenvoerder
  • CONSIGLIO NAZIONALE DELLE RICERCHE
  • UNIVERSITA DI PISA
  • TECHNISCHE UNIVERSITAET GRAZ
  • INFINEON TECHNOLOGIES AUSTRIA AG
  • FUNDACJA MY PACJENCI
  • PANEPISTIMIO IOANNINON

Land(en)

AustriaItalyPolandGreece

Inhoudsopgave

EIC Pathfinder

Financiering tot €3–4 mln voor high‑risk, high‑gain onderzoek naar baanbrekende technologieën binnen Horizon Europe.

Bekijk regeling

Vergelijkbare projecten binnen EIC Pathfinder

ProjectRegelingBedragJaarActie

Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases

The project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU.

EIC Pathfinder€ 3.979.006
2023
Details

Mid-infrared Wearable for Non-invasive biomarker monitoring

The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.

EIC Pathfinder€ 3.991.297
2024
Details

breakthrough technologies for an implantable artificial kidney

KIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs.

EIC Pathfinder€ 3.293.227
2023
Details

Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response

SWEATPATCH aims to develop a non-invasive, real-time monitoring system using sweat VOCs to personalize breast cancer treatment and improve patient outcomes through innovative technology.

EIC Pathfinder€ 2.670.933
2024
Details

A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials

WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.

EIC Pathfinder€ 2.934.318
2023
Details
EIC Pathfinder

Speckle Technology and Digital Biomarkers of Microvascular Function for Monitoring Cardiovascular Diseases

The project aims to develop innovative monitoring instruments for early detection of cardiovascular diseases, integrating advanced technologies to reduce healthcare burdens and costs in the EU.

EIC Pathfinder
€ 3.979.006
2023
Details
EIC Pathfinder

Mid-infrared Wearable for Non-invasive biomarker monitoring

The project aims to develop a wearable device using a miniature Mid-Infrared spectrometer for non-invasive biomarker detection in metabolic syndrome, enhancing early diagnosis and management.

EIC Pathfinder
€ 3.991.297
2024
Details
EIC Pathfinder

breakthrough technologies for an implantable artificial kidney

KIDNEW aims to develop a modular implantable artificial kidney using innovative technologies for improved, cost-effective kidney replacement therapy without immunosuppressive drugs.

EIC Pathfinder
€ 3.293.227
2023
Details
EIC Pathfinder

Remote SWEATSkin PATCH for Monitoring Breast Cancer Therapeutic Response

SWEATPATCH aims to develop a non-invasive, real-time monitoring system using sweat VOCs to personalize breast cancer treatment and improve patient outcomes through innovative technology.

EIC Pathfinder
€ 2.670.933
2024
Details
EIC Pathfinder

A Paradigm Shift in Health Monitoring with Electrospun Enzymatic Neomaterials

WOUNDSENS aims to develop innovative wearable biosensors integrated into smart wound dressings to enhance chronic wound monitoring and improve patient quality of life.

EIC Pathfinder
€ 2.934.318
2023
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschade

Dit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade.

Mkb-innovati...€ 18.067
2024
Details

Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease

TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.

ERC Consolid...€ 1.999.063
2022
Details

Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease

ELIMINATE-CKD aims to enhance chronic kidney disease detection by developing a method to quantify nephron number using multi-omics and machine learning for improved diagnostics and therapies.

ERC Consolid...€ 2.000.000
2024
Details

Improving Kidney Health by Targeting Urinary Biomarkers for Tubular Function

U-Tube aims to identify urinary biomarkers for tubular function to enable early detection and treatment of progressive chronic kidney disease, improving patient outcomes.

ERC Consolid...€ 2.000.000
2024
Details

Haalbaarheid Renal Tracker+

Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren.

Mkb-innovati...€ 20.000
2020
Details
Mkb-innovati...

Ontwikkeling van een diagnostische test voor de vroege detectie van chronische nierschade

Dit project onderzoekt de ontwikkeling van een niet-invasieve test voor de vroege detectie van chronische nierschade.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 18.067
2024
Details
ERC Consolid...

Identification of novel diagnostic, predictive and therapeutic strategies in chronic kidney disease

TargetCKD aims to revolutionize chronic kidney disease management by developing noninvasive diagnostics and novel therapeutics through advanced genomic technologies and interdisciplinary research.

ERC Consolidator Grant
€ 1.999.063
2022
Details
ERC Consolid...

Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease

ELIMINATE-CKD aims to enhance chronic kidney disease detection by developing a method to quantify nephron number using multi-omics and machine learning for improved diagnostics and therapies.

ERC Consolidator Grant
€ 2.000.000
2024
Details
ERC Consolid...

Improving Kidney Health by Targeting Urinary Biomarkers for Tubular Function

U-Tube aims to identify urinary biomarkers for tubular function to enable early detection and treatment of progressive chronic kidney disease, improving patient outcomes.

ERC Consolidator Grant
€ 2.000.000
2024
Details
Mkb-innovati...

Haalbaarheid Renal Tracker+

Het project onderzoekt de haalbaarheid van de Renal Tracker+, een serviceproduct dat nierpatiënten helpt om de impact van levensstijlveranderingen op hun ziekte te monitoren.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 20.000
2020
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.